Langomes, Teresita R.
HRN: 05-96-27 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/19/2023
CEFTRIAXONE 1G (VIAL)
10/19/2023
10/26/2023
IV
2g
Q24H
Complicated UTI
Waiting Final Action
05/11/2024
CEFTRIAXONE 1G (VIAL)
05/11/2024
05/17/2024
IVT
2g
OD
UTI
Waiting Final Action